CYP2F1
Basic information
Region (hg38): 19:41114432-41128381
Previous symbols: [ "CYP2F" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (83 variants)
- not_provided (5 variants)
- EBV-positive_nodal_T-_and_NK-cell_lymphoma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP2F1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000774.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 80 | 86 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 80 | 3 | 4 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP2F1 | protein_coding | protein_coding | ENST00000331105 | 9 | 13935 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.41e-9 | 0.322 | 79498 | 6001 | 40249 | 125748 | 0.205 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.00200 | 311 | 311 | 1.00 | 0.0000196 | 3188 |
Missense in Polyphen | 95 | 100.87 | 0.94178 | 1029 | ||
Synonymous | 0.785 | 124 | 136 | 0.914 | 0.00000893 | 1006 |
Loss of Function | 0.771 | 15 | 18.6 | 0.807 | 9.39e-7 | 207 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.537 | 0.536 |
Ashkenazi Jewish | 0.166 | 0.163 |
East Asian | 0.249 | 0.249 |
Finnish | 0.244 | 0.243 |
European (Non-Finnish) | 0.189 | 0.188 |
Middle Eastern | 0.249 | 0.249 |
South Asian | 0.228 | 0.226 |
Other | 0.192 | 0.188 |
dbNSFP
Source:
- Function
- FUNCTION: May be involved in the metabolism of various pneumotoxicants including naphthalene. Is able to dealkylate ethoxycoumarin, propoxycoumarin, and pentoxyresorufin but possesses no activity toward ethoxyresorufin and only trace dearylation activity toward benzyloxyresorufin. Bioactivates 3- methylindole (3MI) by dehydrogenation to the putative electrophile 3-methylene-indolenine. {ECO:0000269|PubMed:1974816}.;
- Pathway
- Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Oxidation by Cytochrome P450;Tryptophan metabolism;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Xenobiotics;Tyrosine metabolism;Fatty acids;Androgen and estrogen biosynthesis and metabolism;Cytochrome P450 - arranged by substrate type;Leukotriene metabolism;Biological oxidations;Metabolism;Linoleate metabolism;C21-steroid hormone biosynthesis and metabolism;Xenobiotics metabolism;Tryptophan degradation;CYP2E1 reactions;Arachidonic acid metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.824
- rvis_EVS
- 1
- rvis_percentile_EVS
- 90.77
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.208
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.317
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Gene ontology
- Biological process
- organic acid metabolic process;xenobiotic metabolic process;response to toxic substance;naphthalene metabolic process;trichloroethylene metabolic process;epoxygenase P450 pathway;exogenous drug catabolic process;oxidation-reduction process
- Cellular component
- cytoplasm;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle
- Molecular function
- monooxygenase activity;iron ion binding;arachidonic acid epoxygenase activity;steroid hydroxylase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;oxygen binding;heme binding;aromatase activity